RxDoctor Payments Data

Harneet Walia, MD

Sleep Medicine · Miami, FLNPI 1659510618

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,232 of the $18,851 with a category attached, or 70.2%. 17 manufacturers reported payments, led by Eli Lilly at 41.1% of the total. Reporting peaked in 2024 at $9,374 and has fallen 52.2% since, to $4,481 in 2025.

$18,851in general payments, 2019–2025

Across 72 payments — averaging $261.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8K
  • Resmed Corp$4K
  • Lilly USA, LLC$2K
  • Jazz Pharmaceuticals Inc.$1K
  • Inspire Medical Systems, Inc.$1K
  • Itamar Medical Inc$714
  • plus $1K from 11 others
$349,744in research payments, 2019–2025

Across 62 payments — averaging $5641.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$191K
  • Resmed Corp$158K

What the payments were for

  • Consulting fees$13,23270%
  • Travel & lodging$1,6709%
  • Food & beverage$3,62019%
  • Education$3282%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,851 in reported general payments places this provider in the 85th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida

Medicare billing

Part B allowed, 2024
$22,905
Medicare patients
143
Services billed
228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin21$116

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →